Methods for producing virus particles with simplified glycosylation of surface proteins

    公开(公告)号:AU2016204276A1

    公开(公告)日:2016-07-14

    申请号:AU2016204276

    申请日:2016-06-23

    Abstract: Methods for production of virus particles with simplified glycosylation on structural or surface proteins are provided. When used as targets for vaccine production, the conserved nature of such sites generates vaccines that are less sensitive to viral mutations. Use of glycosylation inhibitors for production of viruses with simplified glycosylation profiles are disclosed. An exemplary disclosure of influenza viruses and methods for production of mono-glycosylated influenza virus particles is provided. Methods for production of mono-glycosylated forms of influenza A virus, NIBRG-1 4 (H5N1) are provided.

    Methods for producing virus particles with simplified glycosylation of surface proteins

    公开(公告)号:AU2011323141B2

    公开(公告)日:2016-04-07

    申请号:AU2011323141

    申请日:2011-11-04

    Abstract: Methods for production of virus particles with simplified glycosylation on structural or surface proteins are provided. When used as targets for vaccine production, the conserved nature of such sites generates vaccines that are less sensitive to viral mutations. Use of glycosylation inhibitors for production of viruses with simplified glycosylation profiles are disclosed. An exemplary disclosure of influenza viruses and methods for production of mono-glycosylated influenza virus particles is provided. Methods for production of mono-glycosylated forms of influenza A virus, NIBRG-14 (H5N1) are provided.

    Methods for producing virus particles with simplified glycosylation of surface proteins

    公开(公告)号:AU2011323141A1

    公开(公告)日:2013-06-27

    申请号:AU2011323141

    申请日:2011-11-04

    Abstract: Methods for production of virus particles with simplified glycosylation on structural or surface proteins are provided. When used as targets for vaccine production, the conserved nature of such sites generates vaccines that are less sensitive to viral mutations. Use of glycosylation inhibitors for production of viruses with simplified glycosylation profiles are disclosed. An exemplary disclosure of influenza viruses and methods for production of mono-glycosylated influenza virus particles is provided. Methods for production of mono-glycosylated forms of influenza A virus, NIBRG-14 (H5N1) are provided.

Patent Agency Ranking